The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Huntsman Corp
SWB:HTR
|
US |
|
A
|
AudioCodes Ltd
XMUN:AU1
|
IL |
|
A
|
Autotrader Group PLC
OTC:ATDRF
|
UK |
|
ALK-Abello A/S
OTC:AKBLF
|
DK |
|
C
|
China Construction Bank Corp
XHAM:C6T
|
CN |
|
N
|
NOVONIX Ltd
F:GC3
|
AU |
|
SK Hynix Inc
F:HY9H
|
KR |
|
America Movil SAB de CV
NYSE:AMX
|
MX |
|
D
|
Devon Energy Corp
XMUN:DY6
|
US |
|
Tracsis PLC
F:4T2
|
UK |
|
A
|
Autotrader Group PLC
F:2UA
|
UK |
|
C
|
Comfortdelgro Corporation Ltd
OTC:CDGLF
|
SG |
|
Laboratorios Farmaceuticos ROVI SA
F:41L
|
ES |
|
Batm Advanced Communications Ltd
OTC:BVCLF
|
IL |
|
P
|
Premium Brands Holdings Corp
OTC:PRBZF
|
CA |
|
U
|
United Overseas Bank Ltd
SWB:UOB
|
SG |
|
G
|
Glen Eagle Resources Inc
OTC:GERFF
|
CA |
|
Diamcor Mining Inc
XTSX:DMI
|
CA |
|
Tecogen Inc
F:2T1
|
US |
|
Waratah Minerals Ltd
F:0FS0
|
AU |
|
K
|
Kendrion NV
F:K3E
|
NL |
|
F
|
Firm Capital Mortgage Investment Corp
F:74X
|
CA |
|
G
|
Glen Eagle Resources Inc
XTSX:GER
|
CA |
|
M
|
Medipal Holdings Corp
OTC:MAHLY
|
JP |
Huntsman Corp (HTR)’s 12-month stock price forecast through September 2027 has a consensus target of €9.911, implying 25% upside. The forecast is based on price targets from 16 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
HTR is 9.911 EUR with a low forecast of 8.03 EUR and a high forecast of 14.84 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 5%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 12%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more